Stefano Genovese Selected Research

omega-Chloroacetophenone (Mace)

1/2022	Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study.
1/2017	Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Genovese Research Topics

Disease

31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2008
13	Inflammation (Inflammations) 12/2023 - 02/2013
13	Hyperglycemia 01/2019 - 06/2013
10	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 06/2013
7	Hypertension (High Blood Pressure) 03/2023 - 01/2014
7	Heart Failure 01/2023 - 11/2008
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2016 - 06/2013
5	Myocardial Infarction 01/2023 - 01/2019
4	Body Weight (Weight, Body) 01/2022 - 12/2016
4	Albuminuria 01/2022 - 01/2017
3	Diabetes Complications 06/2022 - 05/2016
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 10/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2015
2	Hypercholesterolemia 03/2023 - 03/2010
2	Dyslipidemias (Dyslipidemia) 01/2023 - 12/2016
2	COVID-19 01/2023 - 01/2022
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 12/2019
2	ST Elevation Myocardial Infarction 10/2022 - 01/2019
2	Weight Gain 10/2021 - 09/2015
2	Weight Loss (Weight Reduction) 10/2021 - 01/2017
2	Diabetes Mellitus 10/2020 - 12/2017
2	Insulin Resistance 05/2016 - 07/2014
2	Hypertriglyceridemia 01/2016 - 03/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 11/2014
2	Thrombosis (Thrombus) 07/2014 - 02/2013
2	Hyperinsulinism (Hyperinsulinemia) 07/2014 - 07/2014
1	Non-ST Elevated Myocardial Infarction 10/2022
1	Prediabetic State (Prediabetes) 06/2022
1	Stroke (Strokes) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Unstable Angina 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Acute Coronary Syndrome 01/2019
1	Proteinuria 02/2018
1	Optic Atrophy 12/2017
1	Wolfram Syndrome (Syndrome, Wolfram) 12/2017
1	Hemorrhage 12/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2017
1	Peptic Ulcer (Peptic Ulcers) 12/2017
1	Chronic Renal Insufficiency 11/2017
1	Glucose Intolerance 01/2017
1	Injection Site Reaction 01/2017
1	Diabetic Angiopathies (Diabetic Angiopathy) 06/2015
1	Hypoxia (Hypoxemia) 06/2015

Drug/Important Bio-Agent (IBA)

17	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2012
11	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2015
9	Insulin (Novolin)FDA Link 01/2022 - 11/2008
7	LipidsIBA 01/2023 - 07/2014
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 01/2017
5	Liraglutide FDA Link 01/2018 - 01/2016
5	Interleukin-6 (Interleukin 6)IBA 11/2014 - 06/2013
5	3-nitrotyrosineIBA 11/2014 - 06/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 02/2013
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 01/2016
4	Triglycerides (Triacylglycerol)IBA 12/2017 - 12/2016
3	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 03/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 02/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022 - 01/2017
3	Uric Acid (Urate)IBA 11/2017 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2017
2	C-Reactive ProteinIBA 10/2020 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 12/2017 - 10/2016
2	oxidized low density lipoproteinIBA 12/2017 - 12/2016
2	HDL CholesterolIBA 01/2017 - 12/2016
2	EndoglinIBA 11/2015 - 06/2015
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2014 - 08/2013
2	AntioxidantsIBA 07/2014 - 12/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2013 - 06/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 03/2023
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2023
1	Ezetimibe (Zetia)FDA Link 01/2023
1	SodiumIBA 01/2023
1	ORALIT (ORS)IBA 10/2022
1	Arginine (L-Arginine)FDA Link 06/2022
1	CreatinineIBA 01/2022
1	dapagliflozinIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2018
1	IronIBA 12/2017
1	SulfurIBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	Exenatide (Byetta)FDA Link 01/2017
1	SmokeIBA 01/2017
1	LDL CholesterolIBA 12/2016
1	Blood Glucose (Blood Sugar)IBA 12/2016
1	FlavonoidsIBA 05/2016
1	empagliflozinIBA 01/2016
1	Glucagon (Glukagon)FDA Link 01/2016
1	Hemoglobins (Hemoglobin)IBA 09/2015

Therapy/Procedure

10	Therapeutics 01/2023 - 10/2013
5	Glycemic Control 01/2022 - 08/2016
2	Cardiac Resynchronization Therapy 01/2015 - 11/2008
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023
1	Continuity of Patient Care 10/2021
1	Percutaneous Coronary Intervention 01/2019